|
U.S. Senators Chuck Grassley and Sheldon Whitehouse have launched a bipartisan investigation into the involvement of private-equity firms in the nation's healthcare sector. The inquiry focuses on private-equity deals affecting hospital systems and aims to assess the financial arrangements and potential harm to patients and clinicians. The investigation aims to understand the impact of private-equity firms on healthcare delivery, patient care, and safety.
|
An outbreak of Rocky Mountain spotted fever has been reported in Southern California, causing at least five illnesses, including three deaths, since July. The U.S. Centers for Disease Control and Prevention (CDC) warns healthcare providers to consider immediate treatment with the antibiotic doxycycline for patients with symptoms of Rocky Mountain spotted fever who have recently traveled to northern Mexico, where the tickborne disease is endemic.
|
The Biden administration is considering overriding patents for high-priced drugs developed with taxpayer money, allowing competitors to produce their versions to reduce costs. The move is part of the administration's broader efforts to address drug pricing issues, and it signals a willingness to use "march-in rights" to challenge drug patents. Pharmaceutical companies, including the lobbying firm Pharmaceutical Research and Manufacturers of America (PhRMA), argue that such actions would hinder innovation and collaboration between the public and private sectors.
|
The PrEPVacc prevention study, a significant HIV vaccine trial, has ceased its vaccine component due to disappointing results in preventing HIV. The trial, which evaluated two experimental HIV vaccines alongside a new form of oral pre-exposure prophylaxis (PrEP), involved 1,500 volunteers in Uganda, Tanzania, and South Africa. The failure is a setback in the decades-long pursuit of an effective HIV vaccine.
|
The Biden administration has once again delayed the ban on menthol cigarettes, pushing the implementation to at least March, with expectations that it will take years for menthol products to be removed from store shelves. Public health organizations, including the American Heart Association, have been advocating for a menthol ban for over a decade, citing its role in contributing to tobacco-related diseases and disproportionately affecting Black Americans.
|
|